Back to User profile » Dr Heather Lauder
Paper published by Dr Heather Lauder:
Original Research
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
Etges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, Wright S
Therapeutics and Clinical Risk Management 2016, 12:1667-1675
Published Date: 11 November 2016